N.B.: This evaluation refers to 2018 and is outdated: display the current evaluation.


Germany (DE)

OpenCorporation rating: 51.63 on 100

Ranking 2018: 97 on 602 companies

Primary and secondary NACE classification:
• Manufacture of pharmaceutical preparations (2120)
• Manufacture of other chemical products nec (2059)

Company description

This is a Germany-based company engaged in the manufacture of chemicals and pharmaceutical products. Its products include innovative prescription drugs, over-the-counter products, oncology and treatment of autoimmune and inflammatory diseases, health protection and mobility. The company was founded in 1668. Its headquarter is located in Darmstadt, Germany.The company is used to be known as Merck E. AG. It is a leading science and technology company in healthcare, life science and performance materials. It is one of the oldest still-operating chemical and pharmaceutical companies in the world. The company's activities in the pharmaceuticals business sector comprise three areas: prescription drugs (Ethicals division), generics (off-patent drugs - Generics division), and self-medication products (Consumer Health Care division). While, it chemicals business sector focuses offers specialty products for the electronics, printing, coatings, cosmetics, food, pharmaceutical and biotech industries.The company researches drugs in the areas oncology and neurodegenerative as well as autoimmune and inflammatory diseases. Also, it markets cardiovascular, fertility, endocrinology, and over-the-counter products as well as products for flat screens and the pharmaceutical, food, cosmetics, packaging, and coatings.

[…] show more

OpenCorporation questionnaire

The read only version of the questionnaire submitted to this company is publicly available: view questionnaire.


The rating is calculated on the following metrics (for more information visit the section Methodology).

score (max is 100)

HQ and subsidiaries

loading subsidiaries

* The position of map pins may not reflect the exact location

Latest news about merck kommanditgesellschaft auf aktien

8 November 2021 - 20:30

Pillola anti Covid, Ema avvia revisione su farmaco Merck

L'Agenzia europea del farmaco ha avviato la revisione dei dati disponibili sulla pillola antivirale molnupiravir

2 March 2021 - 19:22

Vaccini, Joe Biden mette d'accordo i due grandi rivali di Big Pharma per aumentare la produzione

Due fabbriche americane della Merck si metteranno a disposizione della concorrente Johnson&Johnson per assemblare il suo prodotto

› source:  La Repubblica

About this evaluation

This company did not compile the OpenCorporation questionnaire, for this reason this evaluation was made only on data available to the project staff.

Claims and support from the company

If as a company manager or official of MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN you want to enter in touch with our staff, provide more information to OpenCorporation or get an account to access and compile the company questionnaire, please write an email to support@opencorporation.org.

Tell the OpenCorporation team

If you detect corporate behavior in contrast with what emerges from the OpenCorporation corporate rating card in your country, or in the branch where you work, report it to info@opencorporation.org so that our team can take it in account.

More evaluations

Permament links

The link below will always open the 2018 evaluation:

2018: https://www.opencorporation.org/en/ranking/merck-kgaa/2018    url copied

The link below will always open the latest evaluation available:

Last: https://www.opencorporation.org/en/ranking/merck-kgaa/last    url copied